Discovery of potent antiproliferative agents from selected oxygen heterocycles as EGFR tyrosine kinase inhibitors from the U.S. National Cancer Institute database by in silico screening and bioactivity evaluation-Reference-Cited by-同舟云学术

Discovery of potent antiproliferative agents from selected oxygen heterocycles as EGFR tyrosine kinase inhibitors from the U.S. National Cancer Institute database by in silico screening and bioactivity evaluation

Published:2022-02 Issue: Volume:58 Page:128524
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Jiwacharoenchai Nattanan,Saruengkhanphasit Rungroj,Niwetmarin Worawat,Seetaha Supaporn,Choowongkomon Kiattawee,Ruchirawat Somsak,Eurtivong Chatchakorn

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference26 articles.

1. Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations-a review;Stewart;Transl Lung Cancer Res,2015

2. Review on EGFR Inhibitors: Critical Updates;Singh;Mini Rev Med Chem,2016

3. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: Molecular bases for EGFR-targeted therapy;Uribe;Pathol Res Pract,2011

4. Epidermal growth factor receptor expression is associated with poor outcome in cutaneous squamous cell carcinoma;Cañueto;Br J Dermatol,2017

5. Epidermal growth factor receptor (EGFR) overexpression in triple-negative breast cancer: association with clinicopathologic features and prognostic parameters;Hashmi;Surg Exp Pathol,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of new symmetrical and asymmetrical nitrile-containing 1,4-dihydropyridine derivatives as dual kinases and P-glycoprotein inhibitors: synthesis, in vitro assays, and in silico studies;Journal of Enzyme Inhibition and Medicinal Chemistry;2022-09-12

2. Structural analysis of cannabinoids against EGFR-TK leads a novel target against EGFR-driven cell lines;Current Research in Pharmacology and Drug Discovery;2022